Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology

Aim. To investigate the prevalence of clinically significant myocyte bridges (MB) of coronary arteries (CA) in patients hospitalised with the diagnosis “Coronary heart disease (CHD): effort angina”; to assess the rates of acute coronary syndrome (ACS) and myocardial infarction (MI) in anamnesis amon...

Full description

Saved in:
Bibliographic Details
Main Authors: Z. A. Bagmanova, N. A. Mazur, V. V. Plechev, I. M. Karamova, V. G. Rudenko
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2011-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1942
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250328139005952
author Z. A. Bagmanova
N. A. Mazur
V. V. Plechev
I. M. Karamova
V. G. Rudenko
author_facet Z. A. Bagmanova
N. A. Mazur
V. V. Plechev
I. M. Karamova
V. G. Rudenko
author_sort Z. A. Bagmanova
collection DOAJ
description Aim. To investigate the prevalence of clinically significant myocyte bridges (MB) of coronary arteries (CA) in patients hospitalised with the diagnosis “Coronary heart disease (CHD): effort angina”; to assess the rates of acute coronary syndrome (ACS) and myocardial infarction (MI) in anamnesis among patients with MB and intact CA or CA atherosclerosis (AS), with or without arterial hypertension (AH); to identify the specific features of therapeutic strategies in patients with isolated MB or combined CA pathology. Material and methods. In 2003-2009, coronary angiography (CAG) was performed in 10298 patients. Results. In 364 patients (3,5 %), MB were diagnosed: in Group I (n=114), isolated MB; in Group II (n=59), MB and AH; in Group III (n=105), MB and CA AS; and in Group IV (n=75), MB, CA AS, and AH. Individuals with isolated MB and combined MB did not differ by ACS rates. Acute MI prevalence was significantly higher in patients with MB and CA AS (n=16/105; 15,2 %; p1-3=0,001), as well as in patients with MB, CA AS, and AH (n=9/75; 12 %; p1-4=0,014). The highest anamnestic prevalence of MI was observed among individuals with MB, CA AS, and AH (n=35/75; 47 %; p1-4=0,00; p2-4=0,05; p3-4=0,04). Conclusion. CA MB could result in ACS development among patients with chest pain syndrome. Among patients with MB, acute MI variant of ACS develops significantly more often for the combination of MB and CA AS. Our results suggest that the majority of patients with CA MB require pharmaceutical therapy. When conservative treatment is ineffective, or when MB are combined with CA AS, mammary coronary grafting could be recommended.
format Article
id doaj-art-79e26486c83640ea86cd87b8d1552328
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2011-10-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-79e26486c83640ea86cd87b8d15523282025-08-20T03:57:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-10-01105727610.15829/1728-8800-2011-5-72-761654Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathologyZ. A. Bagmanova0N. A. Mazur1V. V. Plechev2I. M. Karamova3V. G. Rudenko4Republican Cardiology DispanserRussian Medical Academy of Post-Diploma Medical EducationBaskhir State Medical UniversityRepublican Cardiology DispanserBaskhir State Medical UniversityAim. To investigate the prevalence of clinically significant myocyte bridges (MB) of coronary arteries (CA) in patients hospitalised with the diagnosis “Coronary heart disease (CHD): effort angina”; to assess the rates of acute coronary syndrome (ACS) and myocardial infarction (MI) in anamnesis among patients with MB and intact CA or CA atherosclerosis (AS), with or without arterial hypertension (AH); to identify the specific features of therapeutic strategies in patients with isolated MB or combined CA pathology. Material and methods. In 2003-2009, coronary angiography (CAG) was performed in 10298 patients. Results. In 364 patients (3,5 %), MB were diagnosed: in Group I (n=114), isolated MB; in Group II (n=59), MB and AH; in Group III (n=105), MB and CA AS; and in Group IV (n=75), MB, CA AS, and AH. Individuals with isolated MB and combined MB did not differ by ACS rates. Acute MI prevalence was significantly higher in patients with MB and CA AS (n=16/105; 15,2 %; p1-3=0,001), as well as in patients with MB, CA AS, and AH (n=9/75; 12 %; p1-4=0,014). The highest anamnestic prevalence of MI was observed among individuals with MB, CA AS, and AH (n=35/75; 47 %; p1-4=0,00; p2-4=0,05; p3-4=0,04). Conclusion. CA MB could result in ACS development among patients with chest pain syndrome. Among patients with MB, acute MI variant of ACS develops significantly more often for the combination of MB and CA AS. Our results suggest that the majority of patients with CA MB require pharmaceutical therapy. When conservative treatment is ineffective, or when MB are combined with CA AS, mammary coronary grafting could be recommended.https://cardiovascular.elpub.ru/jour/article/view/1942acute coronary syndromemyocardial infarctionmyocyte bridges of coronary arteriescoronary angiographyβ-adrenoblockersmammary coronary grafting
spellingShingle Z. A. Bagmanova
N. A. Mazur
V. V. Plechev
I. M. Karamova
V. G. Rudenko
Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
Кардиоваскулярная терапия и профилактика
acute coronary syndrome
myocardial infarction
myocyte bridges of coronary arteries
coronary angiography
β-adrenoblockers
mammary coronary grafting
title Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
title_full Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
title_fullStr Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
title_full_unstemmed Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
title_short Comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
title_sort comparison of clinical course and therapeutic strategy in patients with isolated myocyte bridges of coronary arteries or combined coronary artery pathology
topic acute coronary syndrome
myocardial infarction
myocyte bridges of coronary arteries
coronary angiography
β-adrenoblockers
mammary coronary grafting
url https://cardiovascular.elpub.ru/jour/article/view/1942
work_keys_str_mv AT zabagmanova comparisonofclinicalcourseandtherapeuticstrategyinpatientswithisolatedmyocytebridgesofcoronaryarteriesorcombinedcoronaryarterypathology
AT namazur comparisonofclinicalcourseandtherapeuticstrategyinpatientswithisolatedmyocytebridgesofcoronaryarteriesorcombinedcoronaryarterypathology
AT vvplechev comparisonofclinicalcourseandtherapeuticstrategyinpatientswithisolatedmyocytebridgesofcoronaryarteriesorcombinedcoronaryarterypathology
AT imkaramova comparisonofclinicalcourseandtherapeuticstrategyinpatientswithisolatedmyocytebridgesofcoronaryarteriesorcombinedcoronaryarterypathology
AT vgrudenko comparisonofclinicalcourseandtherapeuticstrategyinpatientswithisolatedmyocytebridgesofcoronaryarteriesorcombinedcoronaryarterypathology